Journal of Medical Biochemistry (Jan 2017)

Heterozygote hemoglobin G-coushatta as the cause of a falsely decreased hemoglobin A1C in an ion-exchange HPLC method

  • Ugur-Kurtoğlu Ayçegül,
  • Eren Esin,
  • Aslan Vedat,
  • Erkal Özgür,
  • Erdal Kurtoğlu,
  • Yilmaz Necat

Journal volume & issue
Vol. 36, no. 3
pp. 270 – 273

Abstract

Read online

Glycated hemoglobin (HbA1c) is used for the assessment of glycémie control in patients with diabetes. The presence of genetic variants of hemoglobin can profoundly affect the accuracy of HbA1c measurement. Here, we report two cases of Hemoglobin G-Coushatta (H BB:c.68A> C) variant that interferes in the measurement of HbA1c by a cationexchange HPLC (CE-HPLC) method. HbA1c was measured by a CE-HPLC method in a Tosoh HLC-723 G7 instrument. The HbA1c levels were 2.9% and 4%. These results alerted us to a possible presence of hemoglobinopathy. In the hemoglobin variant analysis, HbA2 levels were detected as 78.3% and 40.7% by HPLC using the short program for the Biorad Variant II. HbA1c levels were measured by an immunoturbidimetric assay in a Siemens Dimension instrument. HbA1c levels were reported as 5.5% and 5.3%. DNA mutation analysis was performed to detect the abnormal hemoglobin variant. Presence of Hemoglobin G-Coushatta variant was detected in the patients. The Hb G-Coushatta variants have an impact on the determination of glycated hemoglobin levels using CEHPLC resulting in a false low value. Therefore, it is necessary to use another measurement method.

Keywords